KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Return on Equity (2018 - 2026)

Moderna (MRNA) has disclosed Return on Equity for 9 consecutive years, with 0.4% as the latest value for Q1 2026.

  • For Q1 2026, Return on Equity fell 8.0% year-over-year to 0.4%; the TTM value through Mar 2026 reached 0.4%, down 8.0%, while the annual FY2025 figure was 0.29%, 0.0% changed from the prior year.
  • Return on Equity hit 0.4% in Q1 2026 for Moderna, down from 0.31% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.94% in Q1 2022 and bottomed at 0.48% in Q2 2024.
  • Average Return on Equity over 5 years is 0.03%, with a median of 0.3% recorded in 2025.
  • Year-over-year, Return on Equity surged 75bps in 2022 and then tumbled -88bps in 2023.
  • Moderna's Return on Equity stood at 0.45% in 2022, then plummeted by -177bps to 0.35% in 2023, then increased by 10bps to 0.31% in 2024, then dropped by -1bps to 0.31% in 2025, then decreased by -27bps to 0.4% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.4%, 0.31%, and 0.33% for Q1 2026, Q4 2025, and Q3 2025 respectively.